Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yin-Xiang Zhang

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Medical Science|August 4, 2018
Structure and Anti-HIV Activity of Betulinic Acid AnaloguesQiu-Xia Huang, Hong-Fei Chen, Xing-Rui Luo, et al.
Journal of Medicinal Chemistry|June 1, 2022
Structure-Based Discovery of Novel NH<sub>2</sub>-Biphenyl-Diarylpyrimidines as Potent Non-Nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Safety: From NH<sub>2</sub>-Naphthyl-Diarylpyrimidine to NH<sub>2</sub>-Biphenyl-DiarylpyrimidineXin Jin, Li-Min Zhao, Shuai Wang, et al.
Journal of Medicinal Chemistry|January 9, 2026
Cyclization-Inspired Structural Optimization: Designing Potent Non-nucleoside Reverse Transcriptase Inhibitors with Enhanced Safety and SelectivityYin-Xiang Zhang, Christophe Pannecouque, Erik De Clercq, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Medical Science|August 4, 2018
Structure and Anti-HIV Activity of Betulinic Acid AnaloguesQiu-Xia Huang, Hong-Fei Chen, Xing-Rui Luo, et al.
Journal of Medicinal Chemistry|June 1, 2022
Structure-Based Discovery of Novel NH<sub>2</sub>-Biphenyl-Diarylpyrimidines as Potent Non-Nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Safety: From NH<sub>2</sub>-Naphthyl-Diarylpyrimidine to NH<sub>2</sub>-Biphenyl-DiarylpyrimidineXin Jin, Li-Min Zhao, Shuai Wang, et al.
Journal of Medicinal Chemistry|January 9, 2026
Cyclization-Inspired Structural Optimization: Designing Potent Non-nucleoside Reverse Transcriptase Inhibitors with Enhanced Safety and SelectivityYin-Xiang Zhang, Christophe Pannecouque, Erik De Clercq, et al.
Pageof 1